BIO-key adds Cyber Threat Intelligence Services, Cyberlitica to Channel Alliance Partner Program, Helping Customers Address Core Aspects of a Holistic Cybersecurity Program
November 09 2021 - 07:59AM
BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider
of Identity and Access Management (IAM) and Identity-Bound
Biometric (IBB) solutions, today announced the addition of
Cyberlitica, a provider of advanced cyber threat intelligence
services for the enterprise, government, and consumer markets, as
the most recent addition to their Channel Alliance Partner (CAP)
Program.
Organizations looking to prevent cyberattacks and the damage
they cause are in search of technologies that can support their
cybersecurity programs. As the National Institute for Standards and
Technology or NIST framework outlines, there are five functions of
a successful cybersecurity program – Identify, Protect, Detect,
Respond, and Recover. The addition of Cyberlitica as a member of
the BIO-key CAP program is focused on helping customers address
these core aspects as they develop a holistic approach to
cybersecurity.
Cyberlitica offers a comprehensive suite of products and
services available to combat cyber-warfare, account takeover, and
fraud, faced by individuals and companies alike. While BIO-key’s
award-winning IAM [and authentication] platform, PortalGuard,
reduces password-related IT support calls by up to 95%; eliminates
passwords; secures remote access; prevents phishing attacks; meets
cyber insurance requirements; and improves productivity for the
customer’s IT team. PortalGuard offers flexible options for single
sign-on, self-service password reset, and 16 multi-factor
authentication methods. PortalGuard is the only IAM platform to
offer Identity-Bound Biometrics, available on-premises or in the
cloud, as a service (IDaaS).
“Because of the many high-profile companies and government
agencies that we work with, Cyberlitica chooses its partners
very carefully with a vetting process that's one of the strictest
in the industry,” said Bob Schiff, Founder and CEO, Cyberlitica.
“That's why we chose BIO-key as our ‘Best of Breed’ partner for
authentication. We know they have the products and services that
our clients want and will service them with the support that each
client needs to be successful in a very unpredictable
world."
“Customers need multiple, interoperable solutions to solve their
cybersecurity challenges,” said Fred Corsentino, CRO, BIO-key. “We
look forward to working together with Cyberlitica to help customers
improve their security posture, prevent cyberattacks, and solve
their identity and access management challenges.”
For more information about Cyberlitica, please visit their
website. For more information about joining the BIO-key CAP
Program, please visit BIO-key’s website.
About BIO-key International, Inc.
(www.BIO-key.com)BIO-key
has over two decades of expertise in providing authentication
technology for thousands of organizations and millions of users and
is revolutionizing authentication with biometric-centric,
multi-factor identity and access management (IAM) solutions,
including its PortalGuard IAM solution, that provides convenient
and secure access to devices, information, applications, and
high-value transactions. BIO-key's patented software and hardware
solutions, with industry-leading biometric capabilities, enable
large-scale on-premises and Identity-as-a-Service (IDaaS) solutions
as well as customized enterprise and cloud solutions.
About Cyberlitica
(www.cyberlitica.com)Cyberlitica
offers threat intelligence solutions to employers and organizations
of all sizes and across all industries. It provides Dark Web
audit and monitoring services, Domain Intelligence Services
identifying risk from where it originates…The Dark Web. It
delivers 24x7x365 Dark Web monitoring and notification services, as
well as the most cutting-edge insights, professional services, and
customized training solutions that significantly mitigate risk.
BIO-key Safe Harbor Statement All statements
contained in this press release other than statements of historical
facts are "forward-looking statements" as defined in the Private
Securities Litigation Reform Act of 1995 (the "Act"). The words
"estimate," "project," "intends," "expects," "anticipates,"
"believes," and similar expressions are intended to identify
forward-looking statements. Such forward-looking statements are
made based on management's beliefs, as well as assumptions made by,
and information currently available to, management pursuant to the
"safe harbor" provisions of the Act. These statements are not
guarantees of future performance or events and are subject to risks
and uncertainties that may cause actual results to differ
materially from those included within or implied by such
forward-looking statements. These risks and uncertainties include,
without limitation, our history of losses and limited revenue; our
ability to raise additional capital; our ability to protect our
intellectual property; changes in business conditions; changes in
our sales strategy and product development plans; changes in the
marketplace; continued services of our executive management team;
security breaches; competition in the biometric technology
industry; market acceptance of biometric products generally and our
products under development; the duration and severity of the
current coronavirus COVID-19 pandemic and its effect on our
business operations, sales cycles, personnel, and the geographic
markets in which we operate; delays in the development of products
and statements of assumption underlying any of the foregoing as
well as other factors set forth under the caption see "Risk
Factors" in our Annual Report on Form 10-K for the year ended
December 31, 2020 and other filings with the Securities and
Exchange Commission. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date made. Except as required by law, the Company undertakes
no obligation to disclose any revision to these forward-looking
statements whether as a result of new information, future events,
or otherwise. Additionally, there may be other factors of which the
Company is not currently aware that may affect matters discussed in
forward-looking statements and may also cause actual results to
differ materially from those discussed. In particular, the
consequences of the coronavirus outbreak to economic conditions and
the industry in general and the financial position and operating
results of our Company, in particular, have been material, are
changing rapidly, and cannot be predicted.
Engage with BIO-key: Facebook – Corporate:
https://www.facebook.com/BIOkeyInternational/LinkedIn – Corporate:
https://www.linkedin.com/company/bio-key-internationalTwitter –
Corporate: @BIOkeyIntlTwitter – Investors: @BIO_keyIRStockTwits:
BIO_keyIR
BIO-key Media Contact: Erin Knapp Matter
Communications BIO-key@matternow.com914-260-3158
Investor Contacts: William Jones, David Collins
Catalyst IR BKYI@catalyst-ir.com212-924-9800
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Feb 2024 to Mar 2024
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Mar 2023 to Mar 2024